BARDA Consulting

BARDA ConsultingBARDA ConsultingBARDA Consulting
  • Home
  • What We Do
  • About Us
  • Contact
  • More
    • Home
    • What We Do
    • About Us
    • Contact

BARDA Consulting

BARDA ConsultingBARDA ConsultingBARDA Consulting
  • Home
  • What We Do
  • About Us
  • Contact

About Us

BARDA Consulting is a focus of R&D Plus, a consulting firm specialized in helping companies secure and manage nondilutive government funding for research & development projects. 


Our team has helped 100+ organizations secure and manage $10B+ billion dollars in non-dilutive U.S. Government funding for R&D and industrial base expansion projects, including from BARDA and BARDA funded consortiums. Below is a sample of companies and government awards our consultants have supported:

  • Moderna: $10B+ from BARDA and DOD
  • Regeneron: $1B+ from BARDA
  • Vir Biotechnology: $1B+ from BARDA
  • PPD: $1B+ from BARDA, NIAID, and DOD
  • Phlow Corp: $900M+ from BARDA
  • Johnson & Johnson/Janssen/Crucell: $500M+ from BARDA & NIAID
  • Nanotherapeutics/Ology Bioservices/Resilience: $500M+ from DOD, BARDA, and NIAID
  • VenatoRX: $500M+ from BARDA and DOD
  • Sabin Vaccine Institute: $350M+ from BARDA
  • Stratatech: $300M+ from BARDA and DOD
  • Merck: $250M+ from BARDA and DOD
  • IQVIA: $250M+ from BARDA, NIAID, and DOD
  • Cerus Corporation: $230M from BARDA
  • Ridgeback Biotherapeutics: $175M from BARDA
  • Evonik: $150M from DOD and ASPR
  • SafeSource Direct: $145M from ASPR
  • JHP Pharmaceuticals/Par/Endo: $120M+ from BARDA and DOD
  • Vedanta Biosciences: $115M from BARDA
  • United Safety Technology: $90M from DOD and ASPR
  • Locus Biosciences: $85M from BARDA
  • TriLink BioTechnologies: $75M from DOD and ASPR
  • Spero Therapeutics: $75M+ from BARDA, NIAID, and DOD 
  • BioFactura: $70M from BARDA and DOD
  • Visby Medical: $60M+ from BARDA
  • IDBiologics: $60M+ from DOD
  • Novavax: $60M from DOD
  • GeoVax: $50M+ BARDA and DOD
  • Hawaii Biotech: $50M from NIAID
  • Dynavax: $30M+ from DOD
  • Detect: $22M from BARDA
  • Kaleo: $20M+ from DOD 
  • Rapid Micro Biosystems: $15M+ from BARDA

R&D Plus also supports organizations with the pursuit and management of funding from additional U.S. Government agencies, including:

  • ARPA-H: www.ARPA-Hconsulting.com
  • NIAID: www.NIAIDconsulting.com
  • DTRA: www.DTRAconsulting.com
  • DARPA: www.DARPAconsulting.com

Leadership

BARDA proposal support

David Rubenstein, Ph.D.

Dr. Rubenstein has 25+ years of experience in biomedical research, drug/drug target discovery, advancing disruptive biotechnologies, platform development and integration, advanced development, and regulatory affairs spanning the biotech industry, academic institutions,   and government agencies.


David’s technical proficiencies include multi-omics discovery approaches, BSL3/4 laboratory experimentation, data management and interpretation, in silico chemistry, population genetics, and integrating and optimizing AI/ML tools for drug:target interaction. He is a subject matter expert across neuropathology (e.g., chemical dependencies), infectious diseases, and tissue regeneration and   wound healing.


David is a seasoned advisor and published expert on all aspects of product development and R&D of medical countermeasures. He regularly helps life sciences companies identify opportunities for government funding for the development of medical countermeasures, prepare white papers/abstracts/proposals to request funding, negotiate awards, and successfully manage the resulting contracts or grants. 


David has also provided advisory services directly to the highest levels of government agencies within the Pentagon R&D enterprise, including the JPEO, DTRA JSTO, DTRA CTR, and DARPA, as well as public health agencies (e.g., NIH, BARDA, ARPA-H).

BARDA proposal support

Drew Stiles

Drew has 17+ years of experience helping organizations identify opportunities from the U.S. Government for non-dilutive R&D funding, navigate the federal procurement process, prepare proposals, win awards, and successfully manage the resulting programs.


Drew has substantial experience with R&D programs funded by Consortium OTAs, DOD, and HHS ― including BARDA, ASPR, NIH, and ARPA-H.


He also brings supply chain experience working with the U.S. Government on multiple industrial base expansion initiatives to establish domestic manufacturing capabilities for pharmaceuticals and personal protective equipment as a matter of national security.


Drew is well versed in preparing successful white papers, market research abstracts, and full proposals as well as navigating the accounting, compliance, project management, and administration requirements associated with government grants, contracts, and Other Transaction Authority (OTA).


He regularly designs and implements compliant cost accounting structures for organizations receiving their first cost-reimbursable government award. This includes developing indirect rate structures and cost allocation methodologies in accordance with government cost accounting regulations, while also helping contractors to maximize profitability and minimize exposure to compliance risk.

Copyright © 2025 BARDA Consulting - All Rights Reserved.

  • Home
  • What We Do
  • About Us
  • Contact

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept